Hyperfine (HYPR) Net Cash Flow (2021 - 2026)
Hyperfine (HYPR) posted Net Cash Flow of $5.2 million for Q1 2026, down 62.63% on a QoQ basis from $14.0 million in Q4 2025, and up 226.5% year-over-year from $1.6 million in Q1 2025.
Hyperfine (HYPR) Net Cash Flow (2021 - 2026) Analysis & Trends
Hyperfine's Net Cash Flow history runs 6 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- Quarterly Net Cash Flow rose 226.5% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.7 million (up 126.1% YoY) and the FY2025 annual result came in at -$1.6 million, up 95.72% from the prior year.
- Net Cash Flow was $5.2 million for Q1 2026 at Hyperfine, down from $14.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $14.0 million in Q4 2025 and bottomed at -$27.6 million in Q1 2022.
- A 5-year average of -$8.8 million and a median of -$9.4 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow sank 217.16% — and 2025, when it jumped 268.6%.
- Hyperfine's Net Cash Flow stood at -$15.5 million in 2022, then surged by 34.39% to -$10.2 million in 2023, then grew by 18.26% to -$8.3 million in 2024, then soared by 268.6% to $14.0 million in 2025, then plunged by 62.63% to $5.2 million in 2026.
- Business Quant data shows HYPR's Net Cash Flow at $5.2 million in Q1 2026, $14.0 million in Q4 2025, and -$3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | 5.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.24 Mn |
| Mar 31, 2026 | 5.24 Mn |
| Dec 31, 2025 | 14.01 Mn |
| Dec 31, 2025 | 14.01 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Jun 30, 2025 | -7.96 Mn |
| Jun 30, 2025 | -7.96 Mn |
| Mar 31, 2025 | -4.14 Mn |
| Mar 31, 2025 | -4.14 Mn |
| Dec 31, 2024 | -8.31 Mn |
| Dec 31, 2024 | -8.31 Mn |
| Sep 30, 2024 | -7.83 Mn |
| Sep 30, 2024 | -7.83 Mn |
| Jun 30, 2024 | -9.40 Mn |
| Jun 30, 2024 | -9.40 Mn |
| Mar 31, 2024 | -12.60 Mn |
| Mar 31, 2024 | -12.60 Mn |
| Dec 31, 2023 | -10.17 Mn |
| Dec 31, 2023 | -10.17 Mn |